Physician profile
Donna Bolden
NPI 1194729111
$1,044.99
in general payments reported to CMS, 2019-2025
19 companies · $18.42 in 2025
The $18.42 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $91.77 · 2021: $264 · 2022: $32.40 · 2023: $76.61 · 2024: $282 · 2025: $18.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $210.54 | 2021-2024 | Vraylar, Qulipta |
| Glaxosmithkline, LLC. | $206.57 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $109.31 | 2020-2025 | Gardasil 9, Vaxelis, Gardasil |
| Pfizer INC. | $83.81 | 2019-2024 | |
| Amarin Pharma, INC. | $79.72 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.24 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.83 | 2021-2024 | Jardiance |
| Ironshore Pharmaceuticals INC. | $35.64 | 2019 | |
| Genentech USA, INC. | $26.47 | 2019-2022 | |
| Shire North American Group INC | $25.49 | 2019 | |
| Tris Pharma INC | $24.64 | 2024 | Dyanavel Xr |
| Coloplast Corp | $22.68 | 2019 | |
| Xeris Pharmaceuticals, INC. | $22.57 | 2024 | Gvoke Hypopen |
| Takeda Pharmaceuticals U.S.A., INC. | $20.85 | 2021 | |
| Convatec INC. | $20.29 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $18.27 | 2022 | |
| Lilly USA, LLC | $16.19 | 2024 | Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $15.48 | 2020 | |
| Sobi, INC | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Bolden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.